Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
2.
Dermatol Clin ; 13(1): 99-103, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7712657

ABSTRACT

Multiple endocrine neoplasia type 2B/3 is characterized by multiple mucosal neuromas, a marfanoid appearance, medullary thyroid carcinoma, pheochromocytoma, gastrointestinal ganglioneuromatosis, and thickened corneal nerves. This rare syndrome is inherited in an autosomal dominant pattern. Early recognition followed by appropriate screening and treatment can be life-saving.


Subject(s)
Multiple Endocrine Neoplasia Type 2b/genetics , Adrenal Gland Neoplasms/genetics , Adrenal Gland Neoplasms/pathology , Carcinoma/genetics , Carcinoma/pathology , Cornea/innervation , Ganglioneuroma/genetics , Ganglioneuroma/pathology , Gastrointestinal Neoplasms/genetics , Gastrointestinal Neoplasms/pathology , Humans , Marfan Syndrome/pathology , Multiple Endocrine Neoplasia Type 2b/diagnosis , Multiple Endocrine Neoplasia Type 2b/pathology , Neuroma/genetics , Neuroma/pathology , Pheochromocytoma/genetics , Pheochromocytoma/pathology , Thyroid Neoplasms/genetics , Thyroid Neoplasms/pathology
4.
J Am Acad Dermatol ; 27(3): 367-78, 1992 Sep.
Article in English | MEDLINE | ID: mdl-1383293

ABSTRACT

Mycosis fungoides and Sézary syndrome, collectively referred to as cutaneous T-cell lymphoma, are non-Hodgkin's lymphomas that initially appear in the skin. Early-stage disease, limited to the skin, is best treated with sequential topical therapies such as topical nitrogen mustard, psoralen phototherapy (PUVA), or total-skin electron beam therapy. Photopheresis is the first line of therapy for the patient with erythroderma. Systemic therapy is generally reserved for patients with refractory disease and patients who initially present with extracutaneous involvement. Although there are several treatment options for cutaneous T-cell lymphoma, there have been few randomized comparative trials.


Subject(s)
Lymphoma, T-Cell, Cutaneous/therapy , Skin Neoplasms/therapy , Combined Modality Therapy , Humans , Interferons/therapeutic use , Lymphoma, T-Cell, Cutaneous/drug therapy , Lymphoma, T-Cell, Cutaneous/pathology , Lymphoma, T-Cell, Cutaneous/radiotherapy , Mechlorethamine/therapeutic use , Neoplasm Staging , PUVA Therapy , Photochemotherapy , Retinoids/therapeutic use , Skin Neoplasms/drug therapy , Skin Neoplasms/pathology , Skin Neoplasms/radiotherapy
SELECTION OF CITATIONS
SEARCH DETAIL
...